Collect. Czech. Chem. Commun. 2001, 66, 1545-1592
https://doi.org/10.1135/cccc20011545

Synthesis and Cytostatic Activity of N-[2-(Phosphonomethoxy)alkyl] Derivatives of N6-Substituted Adenines, 2,6-Diaminopurines and Related Compounds

Antonín Holý*, Ivan Votruba, Eva Tloušťová and Milena Masojídková

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague 6, Czech Republic

References

1. Neyts J., Snoeck R., Balzarini J., De Clercq E.: Antiviral Res. 1991, 16, 41. <https://doi.org/10.1016/0166-3542(91)90057-X>
1b. De Clercq E.: Rev. Med. Virol. 1993, 3, 85. <https://doi.org/10.1002/rmv.1980030205>
1c. Holý A.: Collect. Czech. Chem. Commun. 1993, 58, 649. <https://doi.org/10.1135/cccc19930649>
1d. Kirsch L. S., Arevalo J. F., Delapaz E. C., Munguia D., De Clercq E., Freeman W. R.: Ophthalmology 1995, 102, 533. <https://doi.org/10.1016/S0161-6420(95)30985-2>
1e. Lalezari J. P., Stagg R. J., Kuppermann B. D., Holland G. N., Kramer F., Ives D. V., Youle M., Robinson M. R., Drew W. L., Jaffe H. S.: Ann. Inter. Med. 1997, 126, 257. <https://doi.org/10.7326/0003-4819-126-4-199702150-00001>
1f. De Clercq E.: Collect. Czech. Chem. Commun. 1998, 63, 480. <https://doi.org/10.1135/cccc19980480>
2a. Hitchcock M. J. M., Jaffe H. S., Martin J. C., Stagg R. J.: Antivir. Chem. Chemother. 1996, 7, 115. <https://doi.org/10.1177/095632029600700301>
2b. Lea A. P., Bryson H. M.: Drugs 1996, 52, 225. <https://doi.org/10.2165/00003495-199652020-00006>
2c. Rahhal F. M., Arevalo J. F., Delapaz E. C., Munguia D., Azen S. P., Freeman W. R.: Ann. Inter. Med. 1996, 125, 98. <https://doi.org/10.7326/0003-4819-125-2-199607150-00003>
2d. Naesens L., De Clercq E.: Nucleosides Nucleotides 1997, 16, 983. <https://doi.org/10.1080/07328319708006121>
3a. Snoeck R., Van Ranst M., Andrei G., De Clercq E., Dewit S., Poncin M., Clumeck N.: New Engl. J. Med. 1995, 333, 943. <https://doi.org/10.1056/NEJM199510053331418>
3b. Van Cutsem E., Snoeck R., Van Ranst M., Fiten P., Opdenakker G., Geboes K., Janssens J., Rutgeerts P., Van Trappen G., De Clercq E.: J. Med. Virol. 1995, 45, 230. <https://doi.org/10.1002/jmv.1890450221>
3c. Naesens L., Snoeck R., Andrei G., Balzarini J., Neyts J., De Clercq E.: Antivir. Chem. Chemother. 1997, 8, 1. <https://doi.org/10.1177/095632029700800101>
3d. Snoeck R., Wellens W., Desloovere C., Van Ranst M., Naesens L., De Clercq E., Feenstra L.: J. Med. Virol. 1998, 54, 219. <https://doi.org/10.1002/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C>
4a. De Clercq E., Holý A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P. C.: Nature 1986, 323, 464. <https://doi.org/10.1038/323464a0>
4b. De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., Holý A.: Antiviral Res. 1987, 8, 261. <https://doi.org/10.1016/S0166-3542(87)80004-9>
4c. Lin J. C., De Clercq E., Pagano J. S.: Antimicrob. Agents Chemother. 1987, 31, 1431. <https://doi.org/10.1128/AAC.31.9.1431>
5a. Pauwels R., Balzarini J., Schols D., Baba M., Desmyter P., Rosenberg I., Holý A., De Clercq E.: Antimicrob. Agents Chemother. 1988, 32, 1025. <https://doi.org/10.1128/AAC.32.7.1025>
5b. Balzarini J., Naesens L., Herdewijn P., Rosenberg I., Holý A., Pauwels R., Baba M., Johns D.G., De Clercq E.: Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 332. <https://doi.org/10.1073/pnas.86.1.332>
5c. Balzarini J., Perno C. F., Schols D., De Clercq E.: Biochem. Biophys. Res. Commun. 1991, 178, 329. <https://doi.org/10.1016/0006-291X(91)91818-W>
6a. Balzarini J., Sobis H., Naesens L., Vandeputte M., De Clercq E.: Int. J. Cancer 1990, 45, 486. <https://doi.org/10.1002/ijc.2910450319>
6b. Balzarini J., Naesens L., Slachmuylders J., Niphuis H., Rosenberg I., Holý A., Schellekens H., De Clercq E.: AIDS 1991, 5, 21. <https://doi.org/10.1097/00002030-199101000-00003>
7. Gangemi J. D., Cozens R. M., De Clercq E., Balzarini J., Hochkeppel H. K.: Antimicrob. Agents Chemother. 1989, 33, 1864. <https://doi.org/10.1128/AAC.33.11.1864>
8a. Hartmann K., Donath A., Beer B., Egberink H. F., Horzinek M. C., Lutz H., Hoffmann- Fezer G., Thum I., Thefeld S.: Vet. Immunol. Immunopathol. 1992, 35, 167. <https://doi.org/10.1016/0165-2427(92)90129-E>
8b. Hartmann K., Balzarini J., Higgins J., De Clercq E., Pedersen N. C.: Antivir. Chem. Chemother. 1994, 5, 13. <https://doi.org/10.1177/095632029400500103>
8c. Hartmann K., Kuffer M., Balzarini J., Naesens L., Goldberg M., Erfle V., Goebel F. D., De Clercq E., Jindřich J., Holý A., Bischofberger N., Kraft W.: J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 1998, 17, 120. <https://doi.org/10.1097/00042560-199802010-00004>
9. Thormar H., Georgsson G., Palsson P. A., Balzarini J., Naesens L., Torsteinsdottir S., De Clercq E.: Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3283. <https://doi.org/10.1073/pnas.92.8.3283>
10a. Tsai C. C., Follis K. E., Sabo A., Grant R. F., Bartz C., Nolte R. E., Benveniste R. E., Bischofberger N.: J. Infect. Dis. 1994, 169, 260. <https://doi.org/10.1093/infdis/169.2.260>
10b. Tsai C. C., Follis K. E., Sabo A., Grant R., Bischofberger N.: J. Infect. Dis. 1995, 171, 1338. <https://doi.org/10.1093/infdis/171.5.1338>
10c. Cundy K. C., Barditch-Crovo P. A., Walker R. E., Collier A. C., Ebeling D., Toole J., Jaffe H. S.: Antimicrob. Agents Chemother. 1995, 39, 2401. <https://doi.org/10.1128/AAC.39.11.2401>
11. Naesens L., Balzarini J., De Clercq E.: Rev. Med. Virol. 1994, 4, 147. <https://doi.org/10.1002/rmv.1980040302>
12a. Starrett J. E., Tortolani D. R., Hitchcock M. J. M., Martin J. C., Mansuri M. M.: Antiviral Res. 1992, 19, 267. <https://doi.org/10.1016/0166-3542(92)90084-I>
12b. Naesens L., Neyts J., Balzarini J., Bischofberger N., De Clercq E.: Nucleosides Nucleotides 1995, 14, 767. <https://doi.org/10.1080/15257779508012468>
12c. Naesens L., Balzarini J., Bischofberger N., De Clercq E.: Antimicrob. Agents Chemother. 1996, 40, 22. <https://doi.org/10.1128/AAC.40.1.22>
12d. Cundy K. C., Sue I. L., Visor G. C., Marshburn J., Nakamura C., Lee W. A., Shaw J. P.: J. Pharm. Sci. 1997, 86, 1334. <https://doi.org/10.1021/js970264s>
13. Cundy K. C., Barditch-Crovo P. A., Walker R. E., Collier A. C., Ebeling D., Toole J., Jaffe H. S.: Antimicrob. Agents Chemother. 1995, 39, 2401. <https://doi.org/10.1128/AAC.39.11.2401>
14a. Heijtink R. A., Dewilde G. A., Kruining J., Berk L., Balzarini J., De Clercq E., Holý A., Schalm S. W.: Antiviral Res. 1993, 21, 141. <https://doi.org/10.1016/0166-3542(93)90050-S>
14b. Yokota T., Konno K., Shigeta S., Holý A., Balzarini J., De Clercq E.: Antivir. Chem. Chemother. 1994, 5, 57. <https://doi.org/10.1177/095632029400500201>
14c. Balzarini J., Kruining J., Heijtink R., De Clercq E.: Antivir. Chem. Chemother. 1994, 5, 360. <https://doi.org/10.1177/095632029400500602>
14d. Gilson R. J., Chopra K. B., Newell A. M., Murray-Lyon I. M., Nelson M. R., Rice S. J., Tedder R. S., Toole J., Jaffe H. S., Weller I. V.: J. Viral Hepat. 1999, 6, 387. <https://doi.org/10.1046/j.1365-2893.1999.00182.x>
14e. Perrillo R., Schiff E., Yoshida E., Statler A., Hirsch K., Wright T., Gutfreund K., Lamy P., Murray A.: Hepatology 2000, 32, 129. <https://doi.org/10.1053/jhep.2000.8626>
14f. Tsiang M., Rooney J. F., Toole J. J., Gibbs C. S.: Hepatology 1999, 29, 1863. <https://doi.org/10.1002/hep.510290626>
14g. Benhamou Y., Bochet M., Thibault V., Calvez V., Fievet M. H., Brosgart C., Vig P., Fry J., Gibbs C. S., Opolon P., Katlama C., Poynard T.: Hepatology 2000, 32, 1199.
14h. Colledge D., Civitico G., Locarnini S., Shaw T.: Antimicrob. Agents Chemother. 2000, 44, 551. <https://doi.org/10.1128/AAC.44.3.551-560.2000>
15a. Naesens L., Balzarini J., Rosenberg I., Holý A., De Clercq E.: Eur. J. Clin. Microbiol. Infect. Dis. 1989, 8, 1043. <https://doi.org/10.1007/BF01975167>
15b. Naesens L., Balzarini J., De Clercq E.: Antiviral Res. 1991, 16, 53. <https://doi.org/10.1016/0166-3542(91)90058-Y>
15c. Naesens L., Neyts J., Balzarini J., Holý A., Rosenberg I., De Clercq E.: J. Med. Virol. 1993, 39, 167. <https://doi.org/10.1002/jmv.1890390215>
15d. Vahlenkamp T. W., De Ronde A., Balzarini J., Naesens L., De Clercq E., van Eijk M. J., Horzinek M. C., Egberink H. F.: Antimicrob. Agents Chemother. 1995, 39, 746. <https://doi.org/10.1128/AAC.39.3.746>
16a. Kreider J. W., Balogh K., Olson R. O., Martin J. C.: Antiviral Res. 1990, 14, 51. <https://doi.org/10.1016/0166-3542(90)90065-F>
16b. Ho H. T., Woods K. L., Konrad S. A., De Boeck H., Hitchcock M. J.: Adv. Exp. Med. Biol. 1992, 312, 159. <https://doi.org/10.1007/978-1-4615-3462-4_16>
17a. Holý A., Masojídková M.: Collect. Czech. Chem. Commun. 1995, 60, 1196. <https://doi.org/10.1135/cccc19951196>
17b. Holý A., Dvořáková H., Masojídková M.: Collect. Czech. Chem. Commun. 1995, 60, 1390. <https://doi.org/10.1135/cccc19951390>
18a. Balzarini J., Holý A., Jindřich J., Naesens L., Snoeck R., Schols D., De Clercq E.: Antimicrob. Agents Chemother. 1993, 37, 332. <https://doi.org/10.1128/AAC.37.2.332>
18b. Balzarini J., Aquaro S., Perno C. F., Witvrouw M., Holý A., De Clercq E.: Biochem. Biophys. Res. Commun. 1996, 219, 337. <https://doi.org/10.1006/bbrc.1996.0234>
19a. Tsai C. C., Follis K. E., Sabo A., Beck T. W., Grant R. F., Bischofberger N., Benveniste R. E., Black R.: Science 1995, 270, 1197. <https://doi.org/10.1126/science.270.5239.1197>
19b. Tsai C. C., Follis K. E., Sabo A., Grant R. F., Bartz C., Nolte R. E., Benveniste R. E., Bischofberger N.: J. Infect. Dis. 1994, 169, 260. <https://doi.org/10.1093/infdis/169.2.260>
19c. Tsai C. C., Emau P., Follis K. E., Beck T. W., Benveniste R. E., Bischofberger N., Lifson J. D., Morton W. R.: J. Virol. 1998, 72, 4265.
19d. Tsai C. C., Emau P., Sun J. C., Beck T. W., Tran C. A., Follis K. E., Bischofberger N., Morton W. R.: J. Med. Primatol. 2000, 29, 248. <https://doi.org/10.1034/j.1600-0684.2000.290318.x>
20. Dvořáková H., Holý A., Rosenberg I.: Collect. Czech. Chem. Commun. 1994, 59, 2069. <https://doi.org/10.1135/cccc19942069>
21a. Holý A., De Clercq E., Votruba I. in: Nucleotide Analogues as Antiviral Agents (J. C. Martin, Ed.), 51. ACS Symp. Ser. 1989.
21b. Bronson J. J., Kim C. U., Ghazzouli I., Hitchcock M. J. M., Kern E. R., Martin J. C. in: Nucleotides as Antiviral Agents (J. C. Martin, Ed.), 72. ACS, Washington 1989.
21c. Holý A. in: Advances in Antiviral Drug Design (E. De Clercq, Ed.), p. 179. JAI Press, Greenwich, CT 1994.
22. Holý A., Günter J., Dvořáková H., Masojídková M., Andrei G., Snoeck R., Balzarini J., De Clercq E.: J. Med. Chem. 1999, 42, 2064. <https://doi.org/10.1021/jm9811256>
23. Hocek M., Masojídková M., Holý A.: Collect. Czech. Chem. Commun. 1995, 60, 875. <https://doi.org/10.1135/cccc19950875>
24. Hocek M., Masojídková M., Holý A., Andrei G., Snoeck R., Balzarini J., De Clercq E.: Collect. Czech. Chem. Commun. 1996, 61, 1525. <https://doi.org/10.1135/cccc19961525>
25a. Hocek M., Masojídková M., Holý A.: Collect. Czech. Chem. Commun. 1997, 62, 136. <https://doi.org/10.1135/cccc19970136>
25b. Česnek M., Hocek M., Holý A.: Collect. Czech. Chem. Commun. 2000, 65, 1357. <https://doi.org/10.1135/cccc20001357>
26. Hocek M., Masojídková M., Holý A.: Tetrahedron 1997, 53, 2291. <https://doi.org/10.1016/S0040-4020(96)01130-1>
27. Holý A., Buděšínský M., Podlaha J., Císařová I.: Collect. Czech. Chem. Commun. 1999, 64, 242. <https://doi.org/10.1135/cccc19990242>
28a. Holý A., De Clercq E.: US 5,977,061 (1999), (filed 1995).
28b. Holý A., Snoeck R., Balzarini J., Andrei G., De Clercq E.: Antiviral Res. 1995, 26, A231 (Abstracts of the International Conference on Antiviral Research, Santa Fe, NM, April 1995).
29a. Meerbach A., Neyts J., Holý A., De Clercq E.: Antiviral Res. 1996, 30, A51 (Abstracts of the 9th International Conference on Antiviral Research, Urabandai, Fukushima, Japan, May 19–24, 1996).
29b. Meerbach A., Holý A., Wutzler P., De Clercq E., Neyts J.: Antivir. Chem. Chemother. 1998, 9, 275. <https://doi.org/10.1177/095632029800900309>
30a. Veselý J., Merta A., Votruba I., Rosenberg I., Holý A.: Neoplasma 1990, 37, 105.
30b. Otová B., Sladká M., Votruba I., Holý A., Křen V.: Folia Biol. (Prague) 1993, 39, 136.
30b. Otová B., Sladká M., Blažek K., Schramlová J., Votruba I., Holý A.: Folia Biol. (Prague) 1993, 39, 142.
30c. Otová B., Křenová D., Zídek Z., Holý A., Votruba I., Křen V.: Folia Biol. (Prague) 1993, 39, 311.
31a. Otová B., Zídek Z., Holý A., Votruba I., Sladká M., Marinov I., Lesková V.: In Vivo 1997, 11, 163.
31b. Otová B., Francová K., Franěk F., Koutník P., Votruba I., Holý A., Sladká M., Schramlová J.: Anticancer Res. 1999, 19, 3173.
31c. Bobková K., Otová B., Marinov I., Mandys V., Panczak A., Votruba I., Holý A.: Anticancer Res. 2000, 20, 1041.
32. Bobková K., Gut I., Mandys V., Holý A., Votruba I., Otová B: Anticancer Res. 2001, in press.
33. Holý A., Zídek, Z., Votruba I.: Collect. Czech. Chem. Commun. 1996, 61, S182. <https://doi.org/10.1135/cccc1996s182>
34. Hatse S., Naesens L., De Clercq E., Balzarini J.: Biochem. Pharmacol. 1999, 58, 311. <https://doi.org/10.1016/S0006-2952(99)00091-X>
35. Rose W. C., Crosswell A. R., Bronson J. J., Martin J. C.: J. Natl. Cancer Inst. 1990, 82, 510. <https://doi.org/10.1093/jnci/82.6.510>
36. Compton M. L., Toole J. J., Paborsky L. R.: Biochem. Pharmacol. 1999, 58, 709. <https://doi.org/10.1016/S0006-2952(99)00138-0>
37. Valeriánová M., Votruba I., Holý A., Mandys V., Otová B.: Anticancer Res. 2001, 21, 2057.
38a. Holý A., Votruba I., Merta A., Černý J., Veselý J., Vlach J., Šedivá K., Rosenberg I., Otmar M., Hřebabecký H., Trávníček M., Vonka V., Snoeck R., De Clercq E.: Antiviral Res. 1990, 13, 295. <https://doi.org/10.1016/0166-3542(90)90014-X>
38b. Merta A., Votruba I., Rosenberg I., Otmar M., Hřebabecký H., Bernaerts R., Holý A.: Antiviral Res. 1990, 13, 209. <https://doi.org/10.1016/0166-3542(90)90066-G>
38c. Foster S. A., Černý J., Cheng Y. C.: J. Biol. Chem. 1991, 266, 238.
38e. Robbins B. L., Greenhaw J., Connelly M. C., Fridland A.: Antimicrob. Agents Chemother. 1995, 39, 2304.
39a. Merta A., Veselý J., Votruba I., Rosenberg I., Holý A.: Neoplasma 1990, 37, 111.
39b. Krejčová R., Horská K., Votruba I., Holý A.: Collect. Czech. Chem. Commun. 2000, 65, 1653. <https://doi.org/10.1135/cccc20001653>
40a. Kramata P., Černý J., Birkuš G., Votruba I., Otová B., Holý A.: Collect. Czech. Chem. Commun. 1995, 60, 1555. <https://doi.org/10.1135/cccc19951555>
40b. Kramata P., Votruba I., Otová B., Holý A.: Mol. Pharmacol. 1996, 49, 1005.
40c. Birkuš G., Votruba I., Holý A., Otová B.: Biochem. Pharmacol. 1999, 58, 487. <https://doi.org/10.1016/S0006-2952(99)00118-5>
41a. Votruba I., Trávníček M., Rosenberg I., Otmar M., Merta A., Hřebabecký H., Holý A.: Antiviral Res. 1990, 13, 287. <https://doi.org/10.1016/0166-3542(90)90013-W>
41b. Balzarini J., Hao Z., Herdewijn P., Johns D. G., De Clercq E.: Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1499. <https://doi.org/10.1073/pnas.88.4.1499>
41c. Cronn R. C., Remington K. M., Preston B. D., North T. W.: Biochem. Pharmacol. 1992, 44, 1375. <https://doi.org/10.1016/0006-2952(92)90539-U>
41d. Suo Z., Johnson K. A.: J. Biol. Chem. 1998, 273, 27250. <https://doi.org/10.1074/jbc.273.42.27250>
42. Krejčová R., Horská K., Votruba I., Holý A.: Biochem. Pharmacol. 2000, 60, 1907. <https://doi.org/10.1016/S0006-2952(00)00512-8>
43. Šedivá K., Ananiev A. V., Votruba I., Holý A., Rosenberg I.: Int. J. Purine Pyrim. Res. 1991, 2, 35.
44. Holý A., Rosenberg I., Dvořáková H.: Collect. Czech. Chem. Commun. 1990, 55, 809. <https://doi.org/10.1135/cccc19900809>
45. Sims B., Mahne-Zizelman D. K., Profit A. A., Prestwich G. D., Sabina R. L., Theibert A. B.: J. Biol. Chem. 1999, 274, 25701. <https://doi.org/10.1074/jbc.274.36.25701>
46a. Horowitz R. M., Grissman T. A.: J. Am. Chem. Soc. 1950, 72, 1518. <https://doi.org/10.1021/ja01160a025>
46b. Ettlinger M. G., Hodgkins J. E.: J. Am. Chem. Soc. 1955, 77, 1831. <https://doi.org/10.1021/ja01612a035>
46c. Roberts J. D., Mazur R. H.: J. Am. Chem. Soc. 1951, 73, 2518.
47. Hocek M., Holý A., Votruba I., Dvořáková H.: J. Med. Chem. 2000, 43, 1817. <https://doi.org/10.1021/jm991167+>
48. Olšanská L., Cihlář T., Votruba I., Holý A.: Collect. Czech. Chem. Commun. 1997, 62, 821. <https://doi.org/10.1135/cccc19970821>